Hrt Financial LP Corbus Pharmaceuticals Holdings, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.21 - $0.53 $5,524 - $13,943	26,309 New	26,309 $6,000
Q4 2021 Feb 14, 2022	SELL	$0.6 - $1.11 $105,736 - $195,611	-176,227 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.01 - $1.82 $132,861 - $239,413	131,546 Added 294.41%	176,227 $179,000
Q2 2021 Aug 16, 2021	SELL	$1.39 - $2.21 $103,111 - $163,940	-74,181 Reduced 62.41%	44,681 $81,000
Q1 2021 May 17, 2021	SELL	$1.27 - $3.42 $971,102 - $2.62 Million	-764,648 Reduced 86.55%	118,862 $234,000
Q4 2020 Feb 16, 2021	BUY	$0.94 - $1.89 $740,156 - $1.49 Million	787,400 Added 819.27%	883,510 $1.1 Million
Q3 2020 Nov 13, 2020	BUY	$1.5 - $9.38 $144,165 - $901,511	96,110 New	96,110 $172,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.